Project Grant N002442010002

The Department of Defense HIV/AIDS Prevention Program (DHAPP), a CFDA 12.350 federal grant program, awarded a $385,000 Cooperative Agreement to Hands On Care, a non-profit organization, on September 30, 2024. The award supports a military-specific HIV/AIDS prevention, care, and treatment program for countries participating in the President's Emergency Plan for AIDS Relief (PEPFAR). The funding will enable Hands On Care to provide technical assistance, implement prevention strategies, expand...

The Department of Defense HIV/AIDS Prevention Program (DHAPP), with CFDA Number 12.350, awarded a $184,767.82 Cooperative Agreement to Alliance Nationale Contre LE Sida on Sep 30, 2024. The funding supports HIV/AIDS prevention, care, and treatment services for military personnel and dependents in Senegal. The Cooperative Agreement aims to reduce HIV transmission, implement prevention strategies, expand testing and treatment, and build sustainable local health infrastructure tailored to...

The Defense Health Agency awarded a $20,465,519.56 Project Grant under the Department of Defense HIV/AIDS Prevention Program (CFDA 12.350) to Jhpiego Corporation on January 14, 2021 with a completion date of January 13, 2025. The grant will fund efforts to support sustainable HIV epidemic control in Zambia as outlined in the grantee's proposal through the DHAPP-ZDF Partnership. Circle of Hope was awarded four sub-awards totaling $XXX to advise on improving customer care approaches across HIV...

The Defense Health Agency awarded Jhpiego Corporation $933,052 under a Cooperative Agreement from October 1, 2021 to September 30, 2023 to support the Department of Defense HIV/AIDS Prevention Program. As part of this award, Jhpiego will provide reproductive, maternal, newborn, child, and adolescent health services, family health and nutrition activities, voluntary medical male circumcision and pre-exposure prophylaxis services, and health system performance improvement efforts to the Botswana...

The Department of Defense HIV/AIDS Prevention Program (DHAPP), a federal grant program under CFDA 12.350, awarded a $712,771 Cooperative Agreement to Labyrinth Global Health, Inc. to provide HIV/AIDS prevention, care, and treatment services for the Republic of Sierra Leone Armed Forces. The project, which runs from September 30, 2024 to September 29, 2025, aims to establish sustainable HIV epidemic control through technical assistance, prevention programming, and capacity building within the...

The U.S. Department of Defense (DoD) awarded a $200,000 Cooperative Agreement to the Network For Religious Leaders Living With Or Affected By HIV / Aids LIMITED in Malawi under the Department of Defense HIV/AIDS Prevention Program (CFDA 12.350). The funding will support the "DHAPP-MDF PARTNERSHIP FOR SUSTAINABLE HIV EPIDEMIC CONTROL THROUGH IMPROVED LINKAGE TO HIV SERVICES BY FAITH COMMUNITY LEADERS (PASHEC)" project, which aims to train and assist the Malawi military in establishing...

This $305,352.20 Cooperative Agreement award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) will support an initiative titled "GUATEMALA, EL SALVADOR, AND HONDURAS: DHAPP CENTRAL AMERICAN ARMED FORCES PARTNERSHIP FOR SUSTAINABLE HIP EPIDEMIC CONTROL." The award is intended to provide technical assistance, capacity building, and innovative solutions to address HIV/AIDS prevention and treatment within the militaries of...

The Defense Health Agency awarded a $364,761 Cooperative Agreement to Co 100 Percent Life, a foreign-owned non-profit organization based in Ukraine, to enhance HIV/AIDS management within the Ukrainian Armed Forces. This award is part of the Department of Defense HIV/AIDS Prevention Program (CFDA 12.350), which aims to provide technical assistance, prevention, care, and treatment services to military personnel and their dependents in various countries. The Cooperative Agreement will support Co...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $2,080,102 Cooperative Agreement under the Global AIDS (CFDA 93.067) program to Humana People To People Congo (Hpp-Congo) for the "TOTAL CONTROL OF THE EPIDEMIC TCE KINSHASA" project. This 5-year project, starting on Sep 30, 2024, aims to combat HIV/AIDS in Kinshasa, Democratic Republic of the Congo through strengthening HIV prevention, testing, treatment, and care services. Key activities to be delivered include...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $6,749,031 five-year Cooperative Agreement under the Global AIDS (CFDA 93.067) program to the Association De Sante Familiale, a local non-profit organization, and PATH, a U.S.-based NGO, for the USHINDI (Victory) Project. The project aims to enhance access to HIV services and achieve epidemic control in seven selected health zones in Haut-Katanga Province, Democratic Republic of the Congo. The key products and services to be...